P1012-500ug | GM-CSF, human recombinant Clinisciences

Background

Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) is secreted by a number of different cell types (including activated T cells, B cells, macrophages, mast cells, endothelial cells and fibroblasts) in response to cytokine or immune and inflammatory stimulation. It was initially characterized as a growth factor that can support the in vitro colony formation of granulocyte-macrophage progenitors and has functions of stimulates the growth and differentiation of hematopoietic precursor cells from various lineages. GM-CSF has also been reported to have a functional role on non-hematopoietic cells and can induce human endothelial cells to migrate and proliferate. Additionally, it can stimulate the proliferation of a number of tumor cell lines, including osteogenic sarcoma, carcinoma and adenocarcinoma cell lines. Human GM-CSF shares 54 % sequences identity with mouse GM-CSF, but has no biological effects across species. GM-CSF is used as a medication to stimulate the production of white blood cells following chemotherapy and has also recently been evaluated in clinical trials for its potential as a vaccine adjuvant in HIV-infected patients.

Reference:

1. Wang JM, Chen ZG, Colotta F, et al. 1988. Behring Inst Mitt: 270-3

2. 1989. N Engl J Med, 320: 253-4

3. Nissen-Druey C. 1989. Nouv Rev Fr Hematol, 31: 99-101

4. Eager RandNemunaitis J. 2005. Mol Ther, 12: 18-27

5. Tran T, Fernandes DJ, Schuliga M, et al. 2005. Br J Pharmacol, 145: 123-31.

Description

Gene ID	1437
Accession #	P04141
Alternate Names	Granulocyte/Macrophage Colony-Stimulating Factor, CSF-2, MGI-1GM, Pluripoietin-α
Source	Escherichia coli.
M.Wt	Approximately 14.5 kDa, a single non-glycosylated polypeptide chain containing 127 amino acids.
AA Sequence	APARSPSPST QPWEHVNAIQ EARRLLNLSR DTAAEMNETV EVISEMFDLQ EPTCLQTRLE LYKQGLRGSL TKLKGPLTMM ASHYKQHCPP TPETSCATQI ITFESFKENL KDFLLVIPFD CWEPVQE
Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Stability & Storage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. - 12 months from date of receipt, -20 to -70 °C as supplied. - 1 month, 2 to 8 °C under sterile conditions after reconstitution. - 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Formulation	Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
Biological Activity	Fully biologically active when compared to standard. The ED₅₀ as determined by a cell proliferation assay using human TF-1 cells is less than 0.1 ng/ml, corresponding to a specific activity of > 1.0 × 10⁷ IU/mg.
Shipping Condition	Gel pack.
Handling	Centrifuge the vial prior to opening.
Usage	For Research Use Only! Not to be used in humans.

Biological Activity

Determined by the dose-dependent stimulation of the proliferation of human TF-1 cells.
ED₅₀	< 0.1 ng/ml.
Specific activity	> 1*10⁷ units/mg.

Quality Control

Purity > 98 % by SDS-PAGE and HPLC analyses.
Endotoxin Level: Less than 1.0 EU/μg of rHuGM-CSF as determined by LAL method.

Datasheet

GM-CSF, human recombinant

Referência P1012-500ug

Contactar o distribuidor local :

Marca : APExBIO Technology

Contactar o distribuidor local :

Background

Description

Biological Activity

Quality Control